This concept is in line with the finding that mice with an Mecp2 null allele develop a metabolic syndrome characterized by insulin resistance, hypertriglyceridemia, obesity13, and altered cholesterol metabolism14, all of which are signs of mitochondrial metabolic imbalance. The gene discussed is MECP2; the disease is metabolic syndrome.